Developer of vaccines against infectious disease, featuring smallpox-related products, investor information, company news, and career opportunities in both Cambridge, England and Massachusetts. ( Nasdaq: ACAM ) ( LSE: ACM )

Supplier of snake venom for anti-serum production, with captive reptile breeding for pet trade. Offer film work, field tours, courses in snake handling, identification and snakebite treatment in Gauteng, South Africa.

Developing therapeutic vaccines against carcinoma, melanoma, leukemia and HIV. Includes pipeline for monoclonal for lupus, RNA-loaded dendritic cell technology and profile of company in Durham, North Carolina.

Develops new classes of diagnostic and therapeutic products for the detection, monitoring, and treatment of immune disorders and autoimmune diseases. based in Needham, Massachusetts. (Nasdaq: AVAN)

Developer and manufacturer offering prevention and treatment of infectious diseases, with pre-clinical research programs, and has established products for HIV and smallpox. Overview includes investor data from Kvistgaard, Denmark.

Company focusing on the development and commercialization of agents to prevent and control antibiotic resistant infections and inflammatory diseases. Includes explanation of modalities, services offered for microbial and tumor testing, details for investors and careers in Montreal, Canada.

Offers prophylactic products, and researches novel treatments for bacterial and viral infections. Includes projects, pipeline, news, global links and contacts for manufacturer in Marburg, Germany.

Develops products used to treat acute sickle cell crisis, vascular diseases, and technologies to improve effectiveness of vaccines, gene and drug delivery, and growth supplements. Based in Los Angeles, California. (Nasdaq: CYTR)

Resource for articles, frequently asked questions, tools, literature, resources, and online services. Maintained by Aldevron LLC, Fargo, North Dakota.

Develops and designs drugs for treatment of acute and chronic inflammatory diseases, infectious diseases and cancer. Overview of technology, corporate development and profile of company in San Diego, California. (Nasdaq: EPMN)

Specializes in viral diagnostics, vaccines, and cancer therapy. Includes current research, news releases and career information in Mount Pleasant, South Carolina.

Manufactures pediatric, adult and clinical vaccines for diseases including hepatitis A and B, diphtheria and tetanus. Includes product list, disease prevention guide and patient information. Manufactured in Belgium and distributed from North Carolina.

Tharapies against hepatitis C, EGFR, the Gag protein of the HIV virus and oncogene-related mutations in human cancer. Includes technology overview, progress of clinical trials, and profile of company in Aurora Colorado.

Development stage company engaged in the development of a vaccine against AIDS. Includes introduction, FAQ, investor data and contacts in Collingwood, Ontario. (Nasdaq:HIVV).

Develops proteosomes as delivery vehicles, with a gene-based testing platform for the identification of disease-causing bacteria from culture and other growth methods. Contacts in North America, with head office in Vancouver, British Columbia. (Nasdaq: IDBE)

Develops, manufactures, and markets proprietary products for treatment of human immunodeficiency virus infection and autoimmune diseases. Technical details for investors, and contacts for headquarters in Carlsbad, California. (Nasdaq: IMNR).

Develops, manufactures and markets formulations for use in immunization programs, including live virus vaccines. Includes patients guide to products, UK and US contacts, with investor relations and corporate communications in Gaithersburg, Maryland. (Nasdaq: AVIR)

Developing a portfolio of immunotherapeutics for infectious diseases and cancer using its proprietary boosting regime. Includes overview of technology, publications and corporate profile, with contacts in Oxford, England and Boston, Massachusetts.

Develops, manufactures and supplies vaccines for prophylaxis and therapy. Includes resource page for bacterial and viral diseases, corresponding products, company biography, links to contacts and sites worldwide.

Manufacturers triple antigen for diphtheria, tetanus and pertussis, and formulations for measles, mumps, rubella and hepatitis B. Includes overview of research, quality assurance, other products, and branches throughout the country.

Creates and develops medical therapies, based on stress protein-based immunotherapeutics. Includes technology, clinical trials and corporate overview, with contacts in Victoria, British Columbia and San Diego, California.

VIDO conducts research in immunization technology, offering partnership with manufacturers for livestock and humans. Includes project overview, patents and contract services available from University of Saskatchewan, Saskatoon, Canada.

IBC conference to include challenges in manufacturing and scale-up, therapeutic and regulatory issues, for two days in Amsterdam, The Netherlands.

Development of vaccines against cancer, tumor immunotherapy using cryptic peptides. Based in Evry Genopole, France.

Developing gene-based treatments for cancer and infectious disease vaccines. Uses DNA technology and proprietary lipids to deliver genes. Includes clinical trial information and contacts in San Diego, California. (Nasdaq: VICL)

Developing therapeutics for autoimmune diseases, AIDS, cancers, infectious diseases based on patented Co-X-Gene platform technology co-expressing antibodies and T cells. Based in Kew, Victoria, Australia.